Protein & Cell,
Год журнала:
2024,
Номер
15(10), С. 744 - 765
Опубликована: Март 13, 2024
Coactivator-associated
arginine
methyltransferase
1
(CARM1)
promotes
the
development
and
metastasis
of
estrogen
receptor
alpha
(ERα)-positive
breast
cancer.
The
function
CARM1
in
triple-negative
cancer
(TNBC)
is
still
unclear
requires
further
exploration.
Here,
we
report
that
proliferation,
epithelial-mesenchymal
transition,
stemness
TNBC.
upregulated
multiple
cancers
its
expression
correlates
with
progression.
Genome-wide
analysis
showed
recruited
by
hypoxia-inducible
factor-1
subunit
(HIF1A)
occupy
promoters
CDK4,
Cyclin
D1,
β-Catenin,
HIF1A,
MALAT1,
SIX1
critically
involved
cell
cycle,
HIF-1
signaling
pathway,
Wnt
VEGF
thereby
modulating
proliferation
invasion
TNBC
cells.
We
demonstrated
physically
associated
directly
interacts
HIF1A.
Moreover,
found
ellagic
acid,
an
inhibitor
CARM1,
can
suppress
inhibiting
CDK4
expression.
Our
research
has
determined
molecular
basis
carcinogenesis
effective
natural
inhibitor,
which
may
provide
new
ideas
drugs
for
therapy.
Cell Reports,
Год журнала:
2023,
Номер
42(7), С. 112792 - 112792
Опубликована: Июль 1, 2023
The
ATR
kinase
safeguards
genomic
integrity
during
S
phase,
but
how
protects
DNA
replication
forks
remains
incompletely
understood.
Here,
we
combine
four
distinct
assays
to
analyze
functions
at
ongoing
and
newly
assembled
upon
inhibition
by
hydroxyurea.
At
forks,
inhibitor
(ATRi)
increases
MRE11-
EXO1-mediated
nascent
degradation
from
PrimPol-generated,
single-stranded
(ssDNA)
gaps.
ATRi
also
exposes
template
ssDNA
through
fork
uncoupling
degradation.
Electron
microscopy
reveals
that
reduces
reversed
increasing
gap-dependent
new
triggers
CtIP-initiated
EXO1,
exposing
ssDNA.
Upon
PARP
inhibition,
preferentially
exacerbates
in
BRCA1/2-deficient
cells
disrupts
the
restored
gap
protection
BRCA1-deficient,
PARP-inhibitor-resistant
cells.
Thus,
mechanisms,
providing
an
extended
view
of
ATR's
stabilizing
forks.
Journal of Biological Chemistry,
Год журнала:
2023,
Номер
299(9), С. 105124 - 105124
Опубликована: Авг. 1, 2023
Coactivator-associated
arginine
methyltransferase
1
(CARM1)
is
an
that
posttranslationally
modifies
proteins
regulate
multiple
levels
of
RNA
production
and
processing.
Its
substrates
include
histones,
transcription
factors,
coregulators
transcription,
splicing
factors.
CARM1
overexpressed
in
many
different
cancer
types,
often
promotes
factor
programs
are
co-opted
as
drivers
the
transformed
cell
state,
a
process
known
addiction.
Targeting
these
oncogenic
pathways
difficult
but
could
be
addressed
by
removing
activity
key
coactivators
on
which
they
rely.
ubiquitously
expressed,
its
KO
less
detrimental
embryonic
development
than
deletion
methyltransferases
protein
5,
suggesting
therapeutic
targeting
may
well
tolerated.
Here,
we
will
summarize
normal
vivo
functions
have
been
gleaned
from
mouse
studies,
expand
transcriptional
regulated
CARM1,
finally
highlight
recent
studies
identified
properties
biological
settings.
This
review
meant
to
kindle
interest
human
drug
therapies
there
currently
no
inhibitors
available
for
use
clinical
trials.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Авг. 17, 2023
Abstract
Activation
of
the
KRAS
oncogene
is
a
source
replication
stress,
but
how
this
stress
generated
and
it
tolerated
by
cancer
cells
remain
poorly
understood.
Here
we
show
that
induction
G12V
expression
in
untransformed
triggers
H3K27me3
HP1-associated
chromatin
compaction
an
RNA
transcription
dependent
manner,
resulting
fork
slowing
cell
death.
Furthermore,
elevated
ATR
necessary
sufficient
for
tolerance
-induced
to
expand
stress-tolerant
(RSTCs).
PrimPol
phosphorylated
at
Ser255,
potential
Chk1
substrate
site,
under
promotes
repriming
maintain
progression
survival
ATR/Chk1-dependent
manner.
However,
ssDNA
gaps
are
heterochromatin
PrimPol-dependent
repriming,
leading
genomic
instability.
These
results
reveal
role
ATR-PrimPol
enabling
precancerous
survive
KRAS-induced
clonally
with
accumulation
Protein & Cell,
Год журнала:
2024,
Номер
15(10), С. 744 - 765
Опубликована: Март 13, 2024
Coactivator-associated
arginine
methyltransferase
1
(CARM1)
promotes
the
development
and
metastasis
of
estrogen
receptor
alpha
(ERα)-positive
breast
cancer.
The
function
CARM1
in
triple-negative
cancer
(TNBC)
is
still
unclear
requires
further
exploration.
Here,
we
report
that
proliferation,
epithelial-mesenchymal
transition,
stemness
TNBC.
upregulated
multiple
cancers
its
expression
correlates
with
progression.
Genome-wide
analysis
showed
recruited
by
hypoxia-inducible
factor-1
subunit
(HIF1A)
occupy
promoters
CDK4,
Cyclin
D1,
β-Catenin,
HIF1A,
MALAT1,
SIX1
critically
involved
cell
cycle,
HIF-1
signaling
pathway,
Wnt
VEGF
thereby
modulating
proliferation
invasion
TNBC
cells.
We
demonstrated
physically
associated
directly
interacts
HIF1A.
Moreover,
found
ellagic
acid,
an
inhibitor
CARM1,
can
suppress
inhibiting
CDK4
expression.
Our
research
has
determined
molecular
basis
carcinogenesis
effective
natural
inhibitor,
which
may
provide
new
ideas
drugs
for
therapy.